107 related articles for article (PubMed ID: 6323626)
1. Interferon production by Epstein-Barr virus in human mononuclear leukocytes.
Kikuta H; Mizuno F; Yano S; Osato T
J Gen Virol; 1984 Apr; 65 ( Pt 4)():837-41. PubMed ID: 6323626
[TBL] [Abstract][Full Text] [Related]
2. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
Kikuta H
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):46-57. PubMed ID: 3009290
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha.
Garner JG; Hirsch MS; Schooley RT
Infect Immun; 1984 Mar; 43(3):920-4. PubMed ID: 6321354
[TBL] [Abstract][Full Text] [Related]
5. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
[TBL] [Abstract][Full Text] [Related]
6. [Induction of IgG and IgM production by Epstein-Barr virus protein].
Zhang YG; Fu M; Liu YF; Gao TW; Pan L; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):103-4. PubMed ID: 15132924
[TBL] [Abstract][Full Text] [Related]
7. Interferon induction in human leukocytes after in vitro exposure to cytomegalovirus or Epstein-Barr virus.
Einhorn L; Einhorn S; Wahren B
Intervirology; 1985; 23(3):140-9. PubMed ID: 2580812
[TBL] [Abstract][Full Text] [Related]
8. Interferon induction by human herpesvirus 6 in human mononuclear cells.
Kikuta H; Nakane A; Lu H; Taguchi Y; Minagawa T; Matsumoto S
J Infect Dis; 1990 Jul; 162(1):35-8. PubMed ID: 1693942
[TBL] [Abstract][Full Text] [Related]
9. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
Gergely P; Ernberg I; Klein G; Steinitz M
Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
[TBL] [Abstract][Full Text] [Related]
10. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
11. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus induces the differentiation of semi-mature dendritic cells from cord blood monocytes.
Jin YY; Wang X; Du J; Cao RM; Law HK; Wang JJ; Chen TX
Hum Immunol; 2014 Apr; 75(4):306-16. PubMed ID: 24530751
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
14. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
[TBL] [Abstract][Full Text] [Related]
15. alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes.
Rodriguez MA; Prinz WA; Sibbitt WL; Bankhurst AD; Williams RC
J Immunol; 1983 Mar; 130(3):1215-9. PubMed ID: 6296232
[TBL] [Abstract][Full Text] [Related]
16. [In vitro immunization of human lymphocytes with Epstein-Barr virus capsid antigen].
Kulikov VV; Krivonos AV; Krasheninnikov ME; Borisova OV; Kal'nov SL
Biull Eksp Biol Med; 1991 Jan; 111(1):62-4. PubMed ID: 1647234
[TBL] [Abstract][Full Text] [Related]
17. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.
Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D
J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.
Lotz M; Tsoukas CD; Fong S; Carson DA; Vaughan JH
Eur J Immunol; 1985 May; 15(5):520-5. PubMed ID: 2581792
[TBL] [Abstract][Full Text] [Related]
19. PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12.
Liu A; Arbiser JL; Holmgren A; Klein G; Klein E
Blood; 2005 Feb; 105(4):1606-13. PubMed ID: 15507528
[TBL] [Abstract][Full Text] [Related]
20. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3643-8. PubMed ID: 3009609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
